Skip to Main Content

Advertisement

Skip Nav Destination

Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial

Cancer Prev Res (Phila) (2022) 15 (10): 661–668.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal